Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells

Epigenetic Control of Gene Expression in the Lung

(2011) Ivana V. Yang et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide

(2011) J Chang et al.   BRITISH JOURNAL OF CANCER

Combination Therapy with Vidaza and Entinostat Suppresses Tumor Growth and Reprograms the Epigenome in an Orthotopic Lung Cancer Model

(2011) Steven A. Belinsky et al.   CANCER RESEARCH

p21Cip1/WAF1mediates cyclin B1 degradation in response to DNA damage

(2011) Laura D. Gillis et al.   CELL CYCLE

Epigenetic-Based Therapies in Cancer

(2011) Sang-Hyun Song et al.   DRUGS

Epigenetic mechanisms and cancer: An interface between the environment and the genome

(2011) Zdenko Herceg et al.   Epigenetics

Silibinin modulates TNF-α and IFN-γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells

(2011) Alpna Tyagi et al.   MOLECULAR CARCINOGENESIS

Silibinin Prevents Lung Tumorigenesis in Wild-Type but not in iNOS-/- Mice: Potential of Real-Time Micro-CT in Lung Cancer Chemoprevention Studies

(2010) K. Ramasamy et al.   CLINICAL CANCER RESEARCH

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy

(2010) Julia M. Wagner et al.   Clinical Epigenetics

Cytotoxicity Mediated by Histone Deacetylase Inhibitors in Cancer Cells: Mechanisms and Potential Clinical Implications

(2009) D. S. Schrump   CLINICAL CANCER RESEARCH

Rational Combinations Using HDAC Inhibitors

(2009) M. Bots et al.   CLINICAL CANCER RESEARCH

Multitargeted therapy of cancer by silymarin

(2008) Kumaraguruparan Ramasamy et al.   CANCER LETTERS

HDAC family: What are the cancer relevant targets?

(2008) Olaf Witt et al.   CANCER LETTERS

Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter

(2008) H. Nian et al.   CARCINOGENESIS

Histone deacetylase inhibitors in cancer therapy

(2008) Min-Jung Lee et al.   CURRENT OPINION IN ONCOLOGY

Lung cancer epigenetics and genetics

(2008) Angela Risch et al.   INTERNATIONAL JOURNAL OF CANCER

Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells

(2008) M. Chittezhath et al.   MOLECULAR CANCER THERAPEUTICS

Histone deacetylase 3 localizes to the mitotic spindle and is required for kinetochore-microtubule attachment

(2008) S. Ishii et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA